Related Experiment Video
Updated: Jul 4, 2026
09:16
Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
Accident risk in patients with epilepsy
Karla Teixeira Souza1, Marilisa M Guerreiro, Carlos A M Guerreiro
1Departament of Neurology, Medical Sciences School, Campinas State University, Campinas, SP, Brazil.
Arquivos De Neuro-Psiquiatria
|June 12, 2008
Summary
Patients with uncontrolled seizures experience significantly more accidents than those seizure-free or with chronic headaches. Epileptic seizures are the primary cause of accidents in epilepsy patients.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- Accidents pose a significant risk to patient safety, particularly in neurological conditions.
- Understanding accident risk factors is crucial for developing effective prevention strategies.
- Epilepsy and chronic headache are common neurological conditions with varying impacts on daily life.
Purpose of the Study:
- To compare accident risk across three patient groups: uncontrolled seizures, seizure-free epilepsy, and chronic headache.
- To identify the primary drivers of accidents in individuals with epilepsy.
- To inform clinical practice and public health initiatives regarding accident prevention in neurological disorders.
Main Methods:
- Prospective longitudinal case-controlled study utilizing semi-structured interviews.
- Data collected from epilepsy and headache outpatient clinics at Hospital das Clínicas of UNICAMP.
- Accident occurrence and types were recorded over a two-year period.
Main Results:
- 81% of patients with uncontrolled seizures reported accidents versus 54% seizure-free and 59% with headache.
- In the uncontrolled seizure group, 89% of accidents were directly related to epileptic seizures.
- Patients with uncontrolled seizures had a higher overall accident rate, with seizures being the main contributor.
Conclusions:
- Uncontrolled epileptic seizures are the most significant factor contributing to accidents in individuals with epilepsy.
- Accident risk is elevated in patients with active epilepsy compared to seizure-free individuals or those with chronic headaches.
- Further research into seizure-related accident prevention is warranted.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...